report cover

Global Ketorolac Injection Market Insights and Forecast to 2028

  • 03 September 2022
  • Life Sciences
  • 107 Pages
  • Report code : 24WT-7319315

Ketorolac Injection Market

1 Study Coverage
1.1 Ketorolac Injection Product Introduction
1.2 Market by Type
1.2.1 Global Ketorolac Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Market by Application
1.3.1 Global Ketorolac Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ketorolac Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Ketorolac Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Ketorolac Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ketorolac Injection Sales by Region
2.4.1 Global Ketorolac Injection Sales by Region (2017-2022)
2.4.2 Global Sales Ketorolac Injection by Region (2023-2028)
2.5 Global Ketorolac Injection Revenue by Region
2.5.1 Global Ketorolac Injection Revenue by Region (2017-2022)
2.5.2 Global Ketorolac Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ketorolac Injection Sales by Manufacturers
3.1.1 Global Top Ketorolac Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Ketorolac Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ketorolac Injection in 2021
3.2 Global Ketorolac Injection Revenue by Manufacturers
3.2.1 Global Ketorolac Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ketorolac Injection Revenue in 2021
3.3 Global Ketorolac Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ketorolac Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ketorolac Injection Sales by Type
4.1.1 Global Ketorolac Injection Historical Sales by Type (2017-2022)
4.1.2 Global Ketorolac Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Ketorolac Injection Sales Market Share by Type (2017-2028)
4.2 Global Ketorolac Injection Revenue by Type
4.2.1 Global Ketorolac Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Ketorolac Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ketorolac Injection Revenue Market Share by Type (2017-2028)
4.3 Global Ketorolac Injection Price by Type
4.3.1 Global Ketorolac Injection Price by Type (2017-2022)
4.3.2 Global Ketorolac Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ketorolac Injection Sales by Application
5.1.1 Global Ketorolac Injection Historical Sales by Application (2017-2022)
5.1.2 Global Ketorolac Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Ketorolac Injection Sales Market Share by Application (2017-2028)
5.2 Global Ketorolac Injection Revenue by Application
5.2.1 Global Ketorolac Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Ketorolac Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
5.3 Global Ketorolac Injection Price by Application
5.3.1 Global Ketorolac Injection Price by Application (2017-2022)
5.3.2 Global Ketorolac Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ketorolac Injection Market Size by Type
6.1.1 North America Ketorolac Injection Sales by Type (2017-2028)
6.1.2 North America Ketorolac Injection Revenue by Type (2017-2028)
6.2 North America Ketorolac Injection Market Size by Application
6.2.1 North America Ketorolac Injection Sales by Application (2017-2028)
6.2.2 North America Ketorolac Injection Revenue by Application (2017-2028)
6.3 North America Ketorolac Injection Market Size by Country
6.3.1 North America Ketorolac Injection Sales by Country (2017-2028)
6.3.2 North America Ketorolac Injection Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ketorolac Injection Market Size by Type
7.1.1 Europe Ketorolac Injection Sales by Type (2017-2028)
7.1.2 Europe Ketorolac Injection Revenue by Type (2017-2028)
7.2 Europe Ketorolac Injection Market Size by Application
7.2.1 Europe Ketorolac Injection Sales by Application (2017-2028)
7.2.2 Europe Ketorolac Injection Revenue by Application (2017-2028)
7.3 Europe Ketorolac Injection Market Size by Country
7.3.1 Europe Ketorolac Injection Sales by Country (2017-2028)
7.3.2 Europe Ketorolac Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ketorolac Injection Market Size by Type
8.1.1 Asia Pacific Ketorolac Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Ketorolac Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Ketorolac Injection Market Size by Application
8.2.1 Asia Pacific Ketorolac Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Ketorolac Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Ketorolac Injection Market Size by Region
8.3.1 Asia Pacific Ketorolac Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Ketorolac Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ketorolac Injection Market Size by Type
9.1.1 Latin America Ketorolac Injection Sales by Type (2017-2028)
9.1.2 Latin America Ketorolac Injection Revenue by Type (2017-2028)
9.2 Latin America Ketorolac Injection Market Size by Application
9.2.1 Latin America Ketorolac Injection Sales by Application (2017-2028)
9.2.2 Latin America Ketorolac Injection Revenue by Application (2017-2028)
9.3 Latin America Ketorolac Injection Market Size by Country
9.3.1 Latin America Ketorolac Injection Sales by Country (2017-2028)
9.3.2 Latin America Ketorolac Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ketorolac Injection Market Size by Type
10.1.1 Middle East and Africa Ketorolac Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ketorolac Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Ketorolac Injection Market Size by Application
10.2.1 Middle East and Africa Ketorolac Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ketorolac Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Ketorolac Injection Market Size by Country
10.3.1 Middle East and Africa Ketorolac Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ketorolac Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Almaject
11.1.1 Almaject Corporation Information
11.1.2 Almaject Overview
11.1.3 Almaject Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Almaject Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Almaject Recent Developments
11.2 Amphastar
11.2.1 Amphastar Corporation Information
11.2.2 Amphastar Overview
11.2.3 Amphastar Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amphastar Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amphastar Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Hikma
11.4.1 Hikma Corporation Information
11.4.2 Hikma Overview
11.4.3 Hikma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hikma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Sagent
11.6.1 Sagent Corporation Information
11.6.2 Sagent Overview
11.6.3 Sagent Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sagent Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sagent Recent Developments
11.7 Alvogen
11.7.1 Alvogen Corporation Information
11.7.2 Alvogen Overview
11.7.3 Alvogen Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alvogen Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alvogen Recent Developments
11.8 Athenex
11.8.1 Athenex Corporation Information
11.8.2 Athenex Overview
11.8.3 Athenex Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Athenex Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Athenex Recent Developments
11.9 BD RX
11.9.1 BD RX Corporation Information
11.9.2 BD RX Overview
11.9.3 BD RX Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BD RX Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BD RX Recent Developments
11.10 Fosun Pharma
11.10.1 Fosun Pharma Corporation Information
11.10.2 Fosun Pharma Overview
11.10.3 Fosun Pharma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Fosun Pharma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fosun Pharma Recent Developments
11.11 Virtus Pharmaceuticals
11.11.1 Virtus Pharmaceuticals Corporation Information
11.11.2 Virtus Pharmaceuticals Overview
11.11.3 Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Virtus Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Virtus Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ketorolac Injection Industry Chain Analysis
12.2 Ketorolac Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ketorolac Injection Production Mode & Process
12.4 Ketorolac Injection Sales and Marketing
12.4.1 Ketorolac Injection Sales Channels
12.4.2 Ketorolac Injection Distributors
12.5 Ketorolac Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ketorolac Injection Industry Trends
13.2 Ketorolac Injection Market Drivers
13.3 Ketorolac Injection Market Challenges
13.4 Ketorolac Injection Market Restraints
14 Key Findings in The Global Ketorolac Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Global Ketorolac Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 15mg/ml
Table 3. Major Manufacturers of 30mg/ml
Table 4. Global Ketorolac Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Ketorolac Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Ketorolac Injection Sales by Region (2017-2022) & (K Units)
Table 7. Global Ketorolac Injection Sales Market Share by Region (2017-2022)
Table 8. Global Ketorolac Injection Sales by Region (2023-2028) & (K Units)
Table 9. Global Ketorolac Injection Sales Market Share by Region (2023-2028)
Table 10. Global Ketorolac Injection Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Ketorolac Injection Revenue Market Share by Region (2017-2022)
Table 12. Global Ketorolac Injection Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Ketorolac Injection Revenue Market Share by Region (2023-2028)
Table 14. Global Ketorolac Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Ketorolac Injection Sales Share by Manufacturers (2017-2022)
Table 16. Global Ketorolac Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Ketorolac Injection Revenue Share by Manufacturers (2017-2022)
Table 18. Ketorolac Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Ketorolac Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2021)
Table 21. Ketorolac Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Ketorolac Injection Product Offered
Table 23. Date of Manufacturers Enter into Ketorolac Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 26. Global Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 27. Global Ketorolac Injection Sales Share by Type (2017-2022)
Table 28. Global Ketorolac Injection Sales Share by Type (2023-2028)
Table 29. Global Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Ketorolac Injection Revenue Share by Type (2017-2022)
Table 32. Global Ketorolac Injection Revenue Share by Type (2023-2028)
Table 33. Ketorolac Injection Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Ketorolac Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 36. Global Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 37. Global Ketorolac Injection Sales Share by Application (2017-2022)
Table 38. Global Ketorolac Injection Sales Share by Application (2023-2028)
Table 39. Global Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Ketorolac Injection Revenue Share by Application (2017-2022)
Table 42. Global Ketorolac Injection Revenue Share by Application (2023-2028)
Table 43. Ketorolac Injection Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Ketorolac Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 46. North America Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 47. North America Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 50. North America Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 51. North America Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 54. North America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 55. North America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 58. Europe Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 59. Europe Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 62. Europe Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 63. Europe Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 66. Europe Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 67. Europe Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Ketorolac Injection Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Ketorolac Injection Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Ketorolac Injection Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Ketorolac Injection Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Ketorolac Injection Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Ketorolac Injection Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Ketorolac Injection Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 105. Almaject Corporation Information
Table 106. Almaject Description and Major Businesses
Table 107. Almaject Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Almaject Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Almaject Recent Developments
Table 110. Amphastar Corporation Information
Table 111. Amphastar Description and Major Businesses
Table 112. Amphastar Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Amphastar Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Amphastar Recent Developments
Table 115. Fresenius Kabi Corporation Information
Table 116. Fresenius Kabi Description and Major Businesses
Table 117. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Fresenius Kabi Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Fresenius Kabi Recent Developments
Table 120. Hikma Corporation Information
Table 121. Hikma Description and Major Businesses
Table 122. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Hikma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Hikma Recent Developments
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Pfizer Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Recent Developments
Table 130. Sagent Corporation Information
Table 131. Sagent Description and Major Businesses
Table 132. Sagent Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Sagent Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sagent Recent Developments
Table 135. Alvogen Corporation Information
Table 136. Alvogen Description and Major Businesses
Table 137. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Alvogen Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Alvogen Recent Developments
Table 140. Athenex Corporation Information
Table 141. Athenex Description and Major Businesses
Table 142. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Athenex Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Athenex Recent Developments
Table 145. BD RX Corporation Information
Table 146. BD RX Description and Major Businesses
Table 147. BD RX Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. BD RX Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. BD RX Recent Developments
Table 150. Fosun Pharma Corporation Information
Table 151. Fosun Pharma Description and Major Businesses
Table 152. Fosun Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Fosun Pharma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Fosun Pharma Recent Developments
Table 155. Virtus Pharmaceuticals Corporation Information
Table 156. Virtus Pharmaceuticals Description and Major Businesses
Table 157. Virtus Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Virtus Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Virtus Pharmaceuticals Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Ketorolac Injection Distributors List
Table 163. Ketorolac Injection Customers List
Table 164. Ketorolac Injection Market Trends
Table 165. Ketorolac Injection Market Drivers
Table 166. Ketorolac Injection Market Challenges
Table 167. Ketorolac Injection Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Ketorolac Injection Product Picture
Figure 3. Global Ketorolac Injection Market Share by Type in 2021 & 2028
Figure 3. 15mg/ml Product Picture
Figure 4. 30mg/ml Product Picture
Figure 5. Global Ketorolac Injection Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Recovery Center
Figure 9. Ketorolac Injection Report Years Considered
Figure 10. Global Ketorolac Injection Sales 2017-2028 (K Units)
Figure 11. Global Ketorolac Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ketorolac Injection Revenue 2017-2028 (US$ Million)
Figure 13. Global Ketorolac Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Ketorolac Injection Sales Market Share by Region (2017-2022)
Figure 15. Global Ketorolac Injection Sales Market Share by Region (2023-2028)
Figure 16. North America Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 17. North America Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Ketorolac Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Ketorolac Injection in the World: Market Share by Ketorolac Injection Revenue in 2021
Figure 28. Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 30. Global Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 31. Global Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 32. Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 33. North America Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 34. North America Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 35. North America Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 36. North America Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 37. North America Ketorolac Injection Sales Share by Country (2017-2028)
Figure 38. North America Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 39. U.S. Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 42. Europe Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 43. Europe Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 45. Europe Ketorolac Injection Sales Share by Country (2017-2028)
Figure 46. Europe Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 47. Germany Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 48. France Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Ketorolac Injection Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Ketorolac Injection Revenue Share by Region (2017-2028)
Figure 58. China Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 61. India Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 69. Latin America Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 71. Latin America Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Ketorolac Injection Sales Share by Country (2017-2028)
Figure 73. Latin America Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 74. Mexico Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Ketorolac Injection Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Ketorolac Injection Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Ketorolac Injection Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 83. Turkey Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 86. Ketorolac Injection Value Chain
Figure 87. Ketorolac Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Ketorolac Injection Market

Leave This Empty: